Scientists establish a `foot in the door’ in precision medicine for oesophageal cancer
Peter Derrick - A patient's story https://youtu.be/D1dXMmrho3E
Scientists at the Universities of Dundee and Aberdeen have established a `foot in the door’ in finding new, precision treatments for patients with oesophageal cancer, one of the hardest forms of the disease to treat.
A decade of work led by Professor Russell Petty, Chair of Medical Oncology in the University of Dundee School of Medicine, and involving colleagues at Dundee and the University of Aberdeen, has now produced a genetic diagnostic test relating to a class of drugs that can extend and improve quality of life for some patients.
By identifying which patients will benefit from being treated with the drug gefitinib – and just as importantly identifying those who get no benefit from it – clinicians can focus on the best treatment plans in each case....Full story here